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Abstract
Scrub typhus is a potentially fatal infectious disease caused by the organism Orientia tsutsugamushi. However, to date, there have been
no clearly identified determinants or reports published on the clinical severity of scrub typhus in liver cirrhosis (LC) patients. This study
was carried out by retrospectively reviewing medical records accumulated over 7 years at a tertiary hospital. Sixteen patients of 160
had underlying LC, and they were defined as ‘cases’; those without underlying LC were defined as ‘controls’. The duration of hospital
stay (23.0 ± 24.8 days for cases and 6.8 ± 7.0 days for controls, p 0.020) and APACHE II scores (14.1 ± 6.0 for cases and 7.2 ± 4.6 for
controls, p <0.001) were, respectively, significantly longer and significantly higher on admission in the cases than in the controls. Surpris-
ingly, hospital mortality was significantly higher in the cases than in the controls (31.3% and 3.5%, respectively, p 0.001). Among the LC
group, the highest Model for End-stage Liver Disease (MELD) score during hospitalization (MELD-Peak) (p 0.024) and the lowest blood
sodium concentration during hospitalization (MELD-Na-Lo) (p 0.003) were higher in fatal cases than in the survivors (MELD-Na-to).
Physicians should be aware of an adverse relationship between LC and scrub typhus, and patients with LC should be advised to avoid
exposure to O. tsutsugamushi, particularly in endemic areas and epidemic seasons.
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Introduction
Scrub typhus, a zoonotic disease prevalent in Asia, is a
potentially fatal infectious disease caused by the organism
Orientia tsutsugamushi [1]. This mite-borne infection is ende-
mic across much of Asia and the Western Pacific region, and
it causes substantial morbidity in the area [1,2]. Eschar is a
typical sign of scrub typhus, which is an acute febrile illness
characterized by abrupt fever, chills, rash, lymphadenopathy,
abdominal pain, and myalgia [3]. Clinically, the manifestations
and complications of scrub typhus are protean. Severe com-
plications have been reported in scrub typhus cases, including
acute respiratory distress syndrome, encephalitis, interstitial
pneumonia, myocarditis and pericarditis, acute renal failure,
and acute hepatic failure [2–7].
However, the determinants of severity have not been
clearly identified. Possible factors considered are infection by
different strains that vary in their degree of virulence,
host factors, differences in nutritional status, accessibility to
medical care, and concomitant infection [1].
Liver cirrhosis (LC) is one of the major public health
problems in Korea, where it is the fourth most common
cause of death [8]. There have been several reports indicat-
ing a close relationship between hepatic dysfunction and
scrub typhus [5,9,10]. These studies recorded hepatocellular
necrosis on the basis of blood chemistry in scrub typhus
patients, namely: 74.5–96.3% for aspartate aminotransferase,
66.7–91.7% for alanine aminotransferase, and 57.4–84.2%
for alkaline phosphatase. However, there are no published
data on the clinical course and impact of scrub typhus in
patients with underlying LC. In this preliminary study, medi-
cal records from the past 7 years (1 January 2000 to 31
December 2006) were retrospectively reviewed to identify
the clinical severity, complications and hospital mortality
of scrub typhus, and the significance of the Model for
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End-stage Liver Disease (MELD) score in patients with
underlying LC.
Patients and Methods
Study population and design
This was a retrospective epidemiological study of patients
who were diagnosed as having scrub typhus during the
past 7 years from 1 January 2000 to 31 December 2006
at a tertiary-care university hospital in Jeonju, Korea. Sero-
logical tests were performed on 1852 patients who had
symptoms of acute seasonal febrile diseases during scrub
typhus epidemic seasons. Among them, 302 cases (age
‡18 years) who had a history of fever with either eschar
or a maculopapular skin eruption and more than two
vague symptoms (such as headache, malaise, myalgia,
coughing, nausea, and abdominal discomfort) were serologi-
cally titrated and diagnosed as having scrub typhus. How-
ever, 142 cases were excluded because of lost records
(n = 5) or the presence of underlying diseases other than
LC (diabetes mellitus, n = 58; hypertension, n = 70; chronic
renal failure, n = 3; stroke, n = 18; bronchial asthma, n = 8;
chronic obstructive pulmonary disease, n = 21; heart fail-
ure, n = 5; atrial fibrillation, n = 3; ischaemic heart disease,
n = 8; aplastic anaemia, n = 3; recent steroid use, n = 3).
The remaining 160 scrub typhus patients were enrolled in
this study. Sixteen patients had underlying LC, and were
defined as ‘cases’; those without underlying disease were
defined as ‘controls’.
Diagnosis of scrub typhus
A positive diagnosis of scrub typhus was defined by a titre of
passive haemagglutination assay (PHA) against O. tsutsugamushi
of ‡1 : 80 in a single serum sample or by a four-fold or
greater increase of titre in the follow-up [11–13]. PHA was
performed at the NeoDIN Medical Institute in Seoul, Korea,
using Genedia Tsutsu PHA II test kits; Genedia Tsutsu
PHA II is a test kit for the qualitative and quantitative detec-
tion of antibodies against O. tsutsugamushi in human serum
based on the PHA. Sheep erythrocytes sensitized by the
Karp and Gilliam strains, including the Boryong strain found
in Korea, were used with the test kit [14,15].
Definitions
Diagnosis of cirrhosis was made on the basis of the clinical
findings of at least two of the following: (i) gastro-oesopha-
geal varices on endoscopy; (ii) serum albumin £3.4 g/dL,
prothrombin time (International Normalized Ratio) ‡1.3, or
serum bilirubin ‡2 mg/dL; and (iii) radiological imaging (ultra-
sonography or computed tomography) suggesting portal
hypertension resulting from cirrhosis [16].
Central nervous system (CNS) involvement was defined by
the presence of CNS-related illnesses such as confusion, sei-
zure, or coma. Involvement of the respiratory system (RS) was
defined by the presence of symptoms, signs and investigation
results supporting evidence of pulmonary oedema, interstitial
pneumonia, pleural effusion, or the need for artificial ventila-
tion. Cardiovascular system (CS) involvement was defined by
the presence of symptoms, signs and investigation results sup-
porting pericardial effusion, new onset of atrial fibrillation, and
ischaemic heart disease. New onset of atrial fibrillation was
defined as such when the symptoms improved with clinical
recovery from scrub typhus. Gastrointestinal system (GS)
involvement was defined by the presence of symptoms, signs
and investigation results supporting peptic ulcer, pancreatitis,
and upper gastrointestinal bleeding. Acute renal failure (ARF)
was defined as such when at least 50% reduction was seen in
glomerular filtration rate (GFR) using the abbreviated modified
diet in renal disease equation, namely: GFR (mL/min/1.73 m2)
= 186Scr
)1.154 · age)0.203 · (1.212 if black) · (0.742 if
female)[17]. Septic shock was defined as sepsis with hypoten-
sion (systolic arterial blood pressure <90 mmHg, or 40 mmHg
less than patient’s baseline blood pressure) for at least 1 h
despite adequate fluid resuscitation [18].
A symptom time (ST) interval was defined as the interval
from the day when clinical symptoms began (prior to admis-
sion) to the day when appropriate treatment with antibiotics
(doxycycline or azithromycin) was started. An admission
time (AT) interval was defined as the interval from the day
of admission to the day when appropriate treatment was
started. Na-D1 was the initial blood sodium level on
admission; Na-Lo was the lowest level of sodium during
hospitalization.
The MELD score (12 and older)
MELD scores were calculated as follows, according to the Uni-
ted Network of Organ Sharing database [19,20]: MELD score
(United Network of Organ Sharing current version) =
9.57 · log10(creatinine, mg/dL) + 3.78 · log10(total bilirubin,
mg/dL) + 11.20 · log10(prothrombin time, INR) + 6.43.
MELD-Na – the model incorporating serum Na and MELD – is
calculated by using the formula MELD-Na = MELD +
1.59(135 – Na), where the minimum value for serum sodium is
120 mEq/L and the maximum is 135 mEq/L [21].
MELD-D1 is the initial MELD score on admission; MELD-
Peak is the highest MELD score during hospitalization.
MELD-Na-D1 is the initial MELD-Na on admission; MELD-
Na-Lo is the MELD-Na at the lowest blood sodium concen-
tration during hospitalization.
420 Clinical Microbiology and Infection, Volume 16 Number 5, May 2010 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 419–424
Statistical analysis
Categorical variables were compared by chi-square test or
Fisher’s exact test, and continuous variables were compared
with the unpaired t-test. SPSS software (version 15.0) was
used throughout, and p-values of less than 0.05 were consid-
ered to be statistically significant.
Results
One hundred and sixty patients were enrolled. Sixteen LC
patients were compared with 144 controls. The mean age of
LC patients was 60.5 ± 12.7 years, and that of controls was
61.1 ± 14.1 years. There was a marginally significant gender
difference between the two groups (p 0.055). Among the
clinical manifestations, headache (p 0.041) and eschar
(p 0.001) were more common in the control group; fever,
chills, sore throat, etc, were not significant between the two
groups (Table 1).
Complications involving the CNS (p 0.040) or ARF
(p 0.001) were more common in the case group. However,
the incidence of complications involving the RS (p 0.319), CS
(p 1.000) and GS (p 0.342) did not differ significantly
between the two groups (Table 2). A summary of initial lab-
oratory findings for case and control groups is shown in
Table 3. Although there were no differences in white blood
cell count, haematocrit or levels of haemoglobin, aspartate
aminotransferase, alanine aminotransferase or total bilirubin
between the two groups, the case group showed significant
differences from the control group in serum platelet count
(p 0.009), albumin (p 0.006), blood urea nitrogen (p 0.012),
GFR (p <0.001), sodium (p 0.001) and potassium (p 0.023).
The duration of hospital stay was significantly greater in
the case group than in the control group (23.0 ± 24.8 and
6.8 ± 7.0 days, respectively, p 0.020) (Table 4). AT and ST
intervals did not show significant differences between the
two groups.
TABLE 1. Demographic and clinical characteristics of 160
study patients diagnosed with scrub typhus
Characteristics Case (n = 16) Control (n = 144) p-Value
Age, mean ± SD (years) 60.5 ± 12.7 61.0 ± 14.0 0.898
Sex, no. (%)
Male 10 (62.5) 51 (35.4) 0.055
Female 6 (37.5) 93 (64.6) –
Clinical manifestations, no. (%)
Fever 13 (81.3) 135 (93.8) 0.104
Chills 13 (81.3) 129 (88.6) 0.395
Sore throat 2 (12.5) 25 (17.4) 1.000
Headache 7 (43.8) 104 (72.2) 0.041
Myalgia 8 (50.0) 91 (63.2) 0.416
Arthralgia 0 (0.0) 8 (5.6) 1.000
General weakness 8 (50.0) 84 (58.3) 0.598
Cough 7 (43.8) 52 (36.1) 0.591
Dyspnea 4 (25.0) 29 (20.1) 0.744
Nausea/vomiting 5 (31.3) 63 (43.8) 0.429
Abdominal pain 7 (43.8) 44 (30.6) 0.396
Skin rash 8 (50.0) 95 (66.0) 0.271
Eschar 4 (25.0) 100 (69.4) 0.001
Lymphadenopathy 0 (0.0) 13 (9.0) 0.366
SD, standard deviation.
TABLE 2. Complications of patients diagnosed as having
scrub typhus
Complications
Case (n = 16),
no. (%)
Control (n = 144),
no. (%) p-Value
Central nervous system 5 (31.3) 16 (11.1) 0.040
Confusion 4 (25.0) 10 (6.9) 0.036
Seizure 1 (6.3) 2 (1.4) 0.273
Coma 0 (0.0) 4 (2.8) 1.000
Respiratory system 5 (31.3) 27 (18.8) 0.319
Pulmonary oedema 1 (6.3) 7 (4.9) 0.578
Pleural effusion 3 (18.8) 14 (9.7) 0.382
Pneumonia 1 (6.3) 5 (3.5) 0.474
Ventilator use 0 (0.0) 1 (0.7) 1.000
Cardiovascular system 0 (0.0) 7 (4.9) 1.000
Pericardial effusion 0 (0.0) 0 (0.0) –
Arrhythmia 0 (0.0) 6 (4.2) 1.000
Ischaemic heart disease 0 (0.0) 1 (0.7) 1.000
Gastrointestinal system 2 (12.5) 10 (6.9) 0.342
Peptic ulcer 2 (12.5) 8 (5.6) 0.263
Pancreatitis 0 (0.0) 0 (0.0) –
Upper gastrointestinal
bleeding
0 (0.0) 2 (1.4) 1.000
Acute renal failure 10 (62.5) 28 (19.4) 0.001
TABLE 3. Laboratory findings on admission of patients
diagnosed as having scrub typhus
Case (n = 18) Control (n = 234) p-Value
WBC (/lL) 10 887 ± 6235 9,027 ± 4,136 0.261
Haematocrit (%) 34.3 ± 4.7 35.3 ± 5.0 0.442
Haemoglobin (g/dL) 11.6 ± 1.8 12.3 ± 1.7 0.153
Platelet (/mm3) 95 937 ± 62 441 161 118 ± 96 137 0.009
AST (IU/L) 172 ± 189 118 ± 106 0.287
ALT (IU/L) 76 ± 70 109 ± 145 0.373
T-bilirubin (mg/dL) 6.62 ± 12.71 0.89 ± 0.73 0.092
Albumin (g/dL) 2.94 ± 0.56 3.40 ± 0.47 0.006
BUN (mg/dL) 29.79 ± 14.62 19.16 ± 11.82 0.012
GFR (mg/dL) 41.16 ± 18.69 77.77 ± 35.78 <0.001
Na+ (mmol/L) 131.69 ± 7.06 136.40 ± 5.30 0.001
K+ (mmol/L) 4.26 ± 0.76 3.85 ± 0.66 0.023
Values are mean ± standard deviation; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; BUN, blood urea nitrogen; GFR, glomerular filtra-
tion rate; WBC, white blood cells.
For each parameter assayed, the differences between normal values and values
obtained from the case group and from the control group were compared for
statistical significance.
TABLE 4. Comparison of ST and AT intervals and duration




(n = 144) p-Value
ST interval, mean ± SD 12.9 ± 15.7 7.2 ± 4.4 0.164
AT interval, mean ± SD 4.7 ± 10.7 1.0 ± 2.5 0.179
Duration of hospital stay,
mean ± SD
23.0 ± 24.8 6.8 ± 7.0 0.020
SD, standard deviation; ST interval, interval from the day when clinical symp-
toms began to the day when appropriate treatment with antibiotics was started;
AT interval, interval from the day of admission to the day when appropriate
treatment was started.
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Despite a significantly higher APACHE II score in the case
group than in the control group (14.1 ± 6.0 and 7.2 ± 4.6,
respectively, p <0.001), no differences were seen in the inci-
dence of septic shock (p 0.4.09) and need for intensive care
(p 1.000) on admission (Table 5). However, surprisingly, the
hospital mortality was significantly higher in the case group
than in the control group (31.3% and 3.5%, respectively,
p 0.001).
In the case group, MELD-Peak (p 0.024), MELD-Na-Lo
was higher in fatal cases than in the survivors. MELD-Na-D1
was higher in the fatal cases than in the survivors, athough
the difference was not statistically different (p 0.071). Na-Lo
(p 0.020) was significantly lower in the fatal cases than in the
survivors. However, MELD-D1 and Na-D1 were not differ-
ent between the two groups (Table 6).
Discussion
The results of the present study revealed that the clinical
gravity of scrub typhus in patients with LC was greater than
in the controls. Although ST and AT intervals were not dif-
ferent between the two groups, mortality, APACHE II score
and duration of hospital stay in the case group were signifi-
cantly higher or longer than in the control. This study shows
that the MELD score, MELD-Na and blood sodium concen-
tration could be used for determining the prognosis in scrub
typhus patients with underlying LC.
Scrub typhus is still regarded as a life-threatening disease
[1]. In this study, the mortality rates in the case and control
groups were 31.5% and 3.5%, respectively. Mortality was sig-
nificantly higher in the case group. To date, no definite risk
factors for fatal outcome in patients with scrub typhus have
been reported, although several possibilities, including the
virulence of the different strains, infection with resistant
strains, host factors, differences in nutritional status, delay of
treatment, and concomitant infection, have been offered as
the causes for fatal outcomes [1].
Moreover, there have been no clinical epidemiological data
relating fatal outcomes in scrub typhus with underlying
comorbid illness, especially with LC. This study highlights the
comorbidity of LC and scrub typhus in relation to poor out-
come, and the suggestion that patients with scrub typhus
with underlying LC have higher mortality than those without
underlying LC is confirmed in this study.
Serious complications of scrub typhus are not uncommon
and may be fatal, particularly in cases with myocarditis,
meningoencephalitis, ARF, and massive gastrointestinal bleed-
ing [2,4,22,23]. Asthe response of scrub typhus to antimicro-
bials is excellent, an early and proper diagnosis and timely
initiation of therapy is essential to prevent serious complica-
tions [3,22]. Deaths are attributable to a variety of factors,
including late presentation and delayed diagnosis [1]. In this
study, the ST and AT intervals of the case group were not
significantly longer than those of the control group. How-
ever, the duration of hospital stay was significantly longer in
the case group than in the control group, supporting the
hypothesis that host factors or prolonged hospital stay were
more important risk factors for fatality than delayed diagno-
sis and treatment.
In this study, CNS involvement and ARF were significantly
more common in the case group than in the control group,
but the difference of complications involving the RS, CS and
GS were not significant. Regarding CNS complications, LC is
a common cause of portal hypertension, and an increase in
portal–systemic shunting may precipitate hepatic encephalop-
athy in cirrhotic patients [24]. Common precipitants of hepa-
tic encephalopathy are gastrointestinal bleeding, excess
dietary protein, azotaemia, infection, and surgery [25]. It may
be that LC patients with scrub typhus are at high risk of
developing CNS complications, especially confusion.
Regarding ARF, LC patients commonly develop renal dis-
turbances such as sodium retention, water retention, and
renal failure [26]. Among these, renal failure is the most
TABLE 5. APACHE II score, intensive-care unit admission





(n = 144) p-Value
Septic shock on admission, no. (%) 3 (18.8) 16 (11.1) 0.409
Intensive-care unit admission, no. (%) 1 (6.3) 11 (7.6) 1.000
APACHE II score, mean ± SD 14.1 ± 6.0 7.2 ± 4.6 <0.001
Mortality, no. (%) 5 (31.3) 4 (3.5) 0.001
SD, standard deviation.
TABLE 6. The comparison of mean Model for End-stage
Liver Disease (MELD) scores and sodium level between
fatal cases and survivors among liver cirrhosis patients
Death (n = 5),
mean ± SD
Survival (n = 11),
mean ± SD p-Value
MELD-D1 19.80 ± 5.76 15.73 ± 6.12 0.230
MELD-Peak 30.00 ± 13.30 16.82 ± 7.80 0.024
Na-D1 127.60 ± 9.02 133.55 ± 5.48 0.121
Na-Lo 122.60 ± 7.80 132.00 ± 6.08 0.020
MELD-Na-D1 29.02 ± 6.26 20.21 ± 9.06 0.071
MELD-Na-Lo 44.94 ± 9.53 23.14 ± 11.80 0.003
SD, standard deviation; MELD-D1, initial MELD score on admission; MELD-Peak,
highest MELD score during admission; Na-D1, initial sodium level on admission;
Na-Lo, lowest blood sodium level during admission; MELD-Na-D1, initial MELD-
Na on admission; MELD-Na-Lo, MELD-Na at the lowest blood sodium level
during admission.
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relevant in clinical practice, because its appearance usually
carries a very poor prognosis [26,27]. The occurrence of
ARF during hospitalization in patients with LC is an indepen-
dent predictive factor for death [26]. Varghese et al. [28]
suggested that renal and hepatic dysfunction in a patient with
scrub typhus at the time of admission predicted a poor out-
come, and that creatinine elevation was an independent
predictor of fatal outcome. Our data show that kidney
function markers such as blood urea nitrogen, GFR and
sodium and potassium levels were significantly deranged in
the case group. These findings strongly support the notion
that patients with underlying LC could progress to ARF.
The MELD score is now widely used in Western coun-
tries to determine the prognosis of patients with cirrhosis
[19,20]. In this study, the case patients with MELD-Peak
showed significantly higher mortality than the controls. In
addition to the MELD parameters, serum sodium is an
important additional predictor of mortality among LC
patients [21,29]. Hyponatraemia has been well described in
association with hepatorenal syndrome, ascites, and other
liver-related mortality [21]. Like the components of the
MELD score, serum sodium is a readily available, reproduc-
ible and objective laboratory test that predicts liver-related
mortality [29]. In this study, Na-D1 was not different
between the two groups. However, Na-Lo was significantly
lower and MELD-Na-Lo was significantly higher in the fatal
cases than in the survivors of the LC group. These results
suggest that the MELD score, MELD-Na and blood sodium
concentration may be useful markers for determining prog-
nosis in LC patients with scrub typhus.
Eschar is a typical sign of scrub typhus [30]. However, the
reported rates of eschar formation show substantial differ-
ences between investigators [31]. It has been reported that
skin colour and aetiological strain of O. tsutsugamushi may be
related to different eschar formation rates [30,32–34]. The
case group described here showed significantly lower eschar
formation rates, but there have been no reports in the liter-
ature explaining the differences in relation to host factors.
To determine the association of particular host factors with
the presence or absence of eschar would require further
studies.
Generally, hypoalbuminaemia and renal insufficiency are
well known to be associated with complications and mortal-
ity in patients with acute infectious diseases [35]. Also, hyp-
erbilirubinaemia and thrombocytopenia may be related to
poor outcome in patients with scrub typhus [3,28]. The
scrub typhus patients with underlying LC showed significant
hypoalbuminaemia, hyperbilirubinaemia and thrombocytope-
nia as compared with controls, and these were thought to
be due to hypersplenism and a combination of underlying LC
and scrub typhus infection in this present study.
This concludes our preliminary study showing that when
cirrhotic patients are exposed to O. tsutsugamushi, it can
have a life-threatening impact upon the patients. Their higher
mortality may be related to poor renal function, worsening
hepatic function, and deranged sodium balance. Therefore,
physicians should be aware of an adverse relationship
between LC and scrub typhus, and all cirrhotic patients
should be advised to avoid exposure to O. tsutsugamushi,
particularly in endemic areas and epidemic seasons.
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